Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Akeso, Astrazeneca, Beigene, Biontech, Brii, Cansino, Cytodyn, Eli Lilly, Everest Medicines, Glaxosmithkline, Glenmark, Innocare, Innovent, Kintor, Moderna, Pfizer, Qpex, RDIF, Sorrento, Takeda, Vir.